Skip to content

MES

  • MES
    • Ulf Kahlert
    • Team
    • Publications
    • Lab infrastructure
  • Research
    • Patient-material biobank
    • Tumor biology
    • Surgical trauma
    • Blood tests
    • Nanomedicine
    • Reproducibility
  • News
  • Cooperations
  • Contact

All news are regularly updated on our institutional homepage

  • Post author:Ulf Kahlert
  • Post published:25. June 2024
  • Post category:Allgemein

The news feature on our institution homepage gives up to date updates on new developments at MES.

Continue ReadingAll news are regularly updated on our institutional homepage
Read more about the article Invited talk

Invited talk

  • Post author:Ulf Kahlert
  • Post published:13. January 2024
  • Post category:Allgemein/News

As the world counts down to the 2030 deadline of the UN agenda, major economies like China and Germany are encountering common challenges, which call…

Continue ReadingInvited talk
Read more about the article Local media press release about blood test for detection of pancreatic cancer

Local media press release about blood test for detection of pancreatic cancer

  • Post author:Ulf Kahlert
  • Post published:13. January 2024
  • Post category:Allgemein/News

Our work on early detection of pancreatic cancer in patients blood raised public interest. We continue to thrive for better future care for patients and…

Continue ReadingLocal media press release about blood test for detection of pancreatic cancer
Read more about the article New publication on transcriptional classification of breast cancer susceptibility to immune therapy

New publication on transcriptional classification of breast cancer susceptibility to immune therapy

  • Post author:Ulf Kahlert
  • Post published:9. February 2023
  • Post category:Allgemein

A chromatin regulator-related gene signature was calculated, and this signature provides the strong independent predictive capability for clinical prognosis and immunotherapy efficacy for patients  …

Continue ReadingNew publication on transcriptional classification of breast cancer susceptibility to immune therapy
Read more about the article New publication on blood-based molecular stratification of pancreatic cancer

New publication on blood-based molecular stratification of pancreatic cancer

  • Post author:Ulf Kahlert
  • Post published:9. February 2023
  • Post category:Allgemein

In a collaboration between the partner sites Heidelberg and Dresden of the National Center for Tumor Diseases (NCT) a blood extracellular-vesicle-transported mRNA signature to discriminate…

Continue ReadingNew publication on blood-based molecular stratification of pancreatic cancer
Read more about the article Cancer Neuroscience

Cancer Neuroscience

  • Post author:Ulf Kahlert
  • Post published:9. February 2023
  • Post category:Allgemein

As part of the NEURO-ONCOLOGY WORKING GROUP (NOA) in the German Cancer Association (DKG) we had the pleasure to moderate a webinar on fundamentals, current…

Continue ReadingCancer Neuroscience
Read more about the article New publication on immune therapy against MYC-driven malignancy

New publication on immune therapy against MYC-driven malignancy

  • Post author:Ulf Kahlert
  • Post published:9. February 2023
  • Post category:Allgemein

The findings suggest a dynamic relationship between MYC amplification and innate immune suppression in MYC amplified neoplasms and support further investigation of phagocytosis modulation as…

Continue ReadingNew publication on immune therapy against MYC-driven malignancy
Read more about the article New Membership

New Membership

  • Post author:Ulf Kahlert
  • Post published:13. December 2022
  • Post category:Allgemein

Accreditation approved to participate in European network on 3R - Replace, Refine, Reduce animal research. Excited to participate in WG1 on "Quality and Translatability of…

Continue ReadingNew Membership
Read more about the article New publication on MET alterations informing on therapy sensitivity

New publication on MET alterations informing on therapy sensitivity

  • Post author:Ulf Kahlert
  • Post published:28. November 2022
  • Post category:Allgemein

MET F/SVs but not genomic amplification, were highly enriched in the secondary glioblastomas (sGBM) and marked worse prognosis. Further molecular and scRNA-seq analysis revealed that…

Continue ReadingNew publication on MET alterations informing on therapy sensitivity
Read more about the article “All THIS MESS: checking validity in clinical studies.”

“All THIS MESS: checking validity in clinical studies.”

  • Post author:Ulf Kahlert
  • Post published:23. November 2022
  • Post category:Allgemein

Data Prevalence is defining co-founder in statistics. Thanks for your visit Dr. Klimova from NCT partner site Dresden.

Continue Reading“All THIS MESS: checking validity in clinical studies.”
  • 1
  • 2
  • 3
  • Go to the next page

Latest

  • All news are regularly updated on our institutional homepage
  • Science meets business
  • Student evaluation
  • Nomination in scientific society
  • MES New Years Brunch 2024

Impressum | Datenschutz

Cookie Consent Banner by Real Cookie Banner